Form 4: Twist Bioscience COO Sells Shares to Cover Tax Obligations

Patrick John Finn, President and COO of Twist Bioscience, sold 2,422 shares of common stock on January 23, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On January 23, 2025, Patrick John Finn, the President and COO of Twist Bioscience Corp, sold 2,422 shares of common stock.
• The sale was executed at a price of $50.1654 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Finn directly owns 272,044 shares of Twist Bioscience Corp.
• The sale was mandated by the issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell to cover taxes) and doesn't indicate any significant positive or negative sentiment.

Management Comments

• The sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

Sales to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and employees.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates